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nanoparticles in human SHSY5Y neuronal cells
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Iron oxide nanoparticles (ION) have been widely used in biomedical applications, for both diagnosis and
therapy, due to their unique magnetic properties. They are intensively explored in neuromedicine mostly
because of their ability to cross the blood brain barrier. Hence, their potential harmful eﬀects on neuronal
cells need to be carefully assessed. The objective of this study was to evaluate the toxicity of silica-coated
ION (S-ION) (10–200 µg ml−1) on human neuronal SHSY5Y cells. Alterations in the cell cycle, cell death
by apoptosis or necrosis, and membrane integrity were assessed as cytotoxicity parameters. Genotoxicity
was determined by a γH2AX assay, a micronucleus (MN) test, and a comet assay. Complementarily, poss-
ible eﬀects on DNA damage repair were also analysed by means of a DNA repair competence assay. All
analyses were performed in complete and serum-free cell culture media. Iron ion release from the nano-
particles was notable only in complete medium. Despite being eﬀectively internalized by the neuronal
cells, S-ION presented in general low cytotoxicity; positive results were only obtained in some assays at
the highest concentrations and/or the longest exposure time tested (24 h). Genotoxicity evaluations in
serum-free medium were negative for all conditions assayed; in complete medium, dose and time-
dependent increase in DNA damage not related to the production of double strand breaks or chromo-
some loss (according to the results of the γH2AX assay and MN test), was obtained. The presence of
serum slightly inﬂuenced the behaviour of S-ION; further studies to investigate the formation of a protein
corona and its role in nanoparticle toxicity are necessary.
Introduction
Since the birth of nanotechnology, iron oxide nanoparticles
(ION) have gained interest for a wide variety of applications.
Due to their unique magnetic properties ION have been widely
utilized in various biomedical applications for both diagnosis
and therapy, such as contrast agents in magnetic resonance
imaging,1–3 heating mediators for cancer therapy,4 carriers for
delivery of drugs5,6 and genes.7,8 Apart from these main appli-
cations, ION are intensively explored in neuromedicine mostly
because they have the ability to cross the blood brain
barrier.9,10 This ability, together with their limited toxic poten-
tial, makes them very suitable for use as promising diagnostic
and therapeutic tools for nervous system malignancies.
Considering that iron oxides occur naturally as nanosized
crystals in the earth’s crust,11 and that ION have already been
used in clinical applications,12 it could seem that there is no
underlying risk associated with these nanoparticles. Although
some studies in the literature have shown that ION are less
toxic than other types of metal nanoparticles,11,13,14 systematic
studies on their eﬀects on the human nervous system are rare,
and their results have been inconsistent.15 Hence, considering
the relevant uses and promising applications of ION in the
neuromedicine field, their potential harmful eﬀects on neuro-
nal cells need to be carefully assessed.
Naked ION tend to form agglomerates becoming unstable
over certain periods of time; they can be easily trapped by the
immune system as foreign materials, which means that they
cannot reach the desired target; and are chemically highly
active and easily oxidized in air, resulting frequently in loss of
magnetism and dispensability.16,17 To solve these problems,
the surface of nanoparticles may be modified by coating with a
number of materials for diﬀerent purposes, and surface func-
tionalisation may play a key role not only in regulating the cell-
membrane penetration but also in aﬀecting the cell activity.18
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ION functionalized with diﬀerent surface chemicals have been
tested in diﬀerent neuronal cell lines, showing conflicting
results. While plain ION show a low health hazard,19 surface
functionalisation can trigger very diﬀerent cellular
responses.20 Thus, exposure to dimercaptosuccinic acid-coated
ION (maghemite) caused a dose-dependent reduction of viabi-
lity and capacity of PC12 rat cells to extend neurites in
response to the nerve growth factor.21 Similar results were
obtained for ION coated with dextran, carboxydextran, lipid
and citrate in the same cell type.22 Besides, in the same study
diﬀerent cytotoxic potentials were observed on c17.2 mouse
neural progenitor cells; the citrate-coated ION were the most
toxic and the lipid-coated ones were the least toxic, under the
experimental conditions used. In contrast, polyethylene glycol-
coated ION increased the eﬃciency of neurite outgrowth in a
dose-dependent manner in nerve growth factor-stimulated
PC12 cells.14 Thus, further and more detailed studies, particu-
larly those employing human neural cells, are required to
identify any potential toxicity associated with the use of ION
with particular surface coatings.
Among all the possible surface modifications for ION, silica
(SiO2) coating has several advantages that make it especially
suitable to be employed for medical purposes. For instance,
silica-coated ION (S-ION) are negatively charged at blood pH
helping to avoid aggregate formation in body fluids,5 and its
transparent matrix allows the eﬃcient passage of excitation
and emission light, which is a relevant property for imaging
diagnosis.23 However, their potential toxicity on the nervous
system has not been deeply addressed.
Therefore, the objective of this study was to evaluate the toxi-
city of S-ION on human neuronal SHSY5Y cells. To that aim,
alterations in the cell cycle, cell death by apoptosis or necrosis,
and membrane integrity were assessed as cytotoxicity para-
meters. Besides, genotoxicity was determined by evaluating
the levels of phosphorylation of H2AX histone (γH2AX assay),
a micronucleus (MN) test, and a comet assay. Complementarily,
possible eﬀects of S-ION on DNA damage repair were also ana-
lysed by means of a DNA repair competence assay.
Materials and methods
Chemicals
Bleomycin (BLM) (CAS no. 9041-93-4), camptothecin (Campt)
(CAS no. 7689-03-4), mytomycin C (MMC) (CAS no. 50-07-7),
hydrogen peroxide (H2O2), and propidium iodide (PI) were pur-
chased from Sigma-Aldrich Co. BLM, Campt and MMC were
dissolved in sterile distilled water prior use.
Nanoparticle preparation
Silica-coated magnetite nanoparticles were synthesized and
prepared as stable water suspensions (5 mg ml−1) as described
by Yi et al.24 Prior to each treatment, a stock suspension (1 mg
ml−1) was prepared in incomplete (serum-free) or complete
SHSY5Y culture medium (see composition below), and was
sonicated in a water bath for 5 min. Serial dilutions were
carried out to obtain the diﬀerent test concentrations, and
sonicated in the water bath for an additional 5 min period.
Physicochemical characteristics of these nanoparticles (par-
ticle size and morphology, surface chemistry, and hydro-
dynamic size and zeta potential in water, complete and
incomplete SHSY5Y medium) were previously determined.25
Dissolved iron concentrations in the cell culture media and
artificial lysosomal fluid
To analyse the release of iron ions from the S-ION, suspen-
sions (5, 10, 25, 50, 75, 100, 150, 175, 200, 250 and 300 μg
ml−1) were incubated in incomplete or complete cell culture
medium and in artificial lysosomal fluid (ALF) for 3, 6 and
24 h at 37 °C in a humidified 5% CO2 environment. The ALF
solution (pH 4.5) was prepared as previously described by
Midander et al.26 After centrifugation at 14 000 rpm for 30 min,
the S-ION solid phase was removed from the liquid medium.
Flame atomic absorption spectroscopy (FAAS) (Thermoelemen-
tal Solaar S4 v.10.02) was used to quantify the iron content in
the supernatant. Cell culture media without nanoparticles
being subjected to the same experimental conditions were
used as negative controls.
Cell culture and S-ION treatment
Human neuroblastoma SHSY5Y cells (European Collection of
Cell Cultures) were grown in the nutrient mixture, EMEM/F12
(1 : 1) with 1% non-essential amino acids, 1% antibiotic and
an antimycotic solution, supplemented with 10% heat inacti-
vated foetal bovine serum (FBS) (all from Invitrogen) in a
humidified incubator at 37 °C with 5% CO2. To carry out the
experiments, cells were seeded in 96-well plates (5–6 × 104 cells
per well), and allowed to adhere for 24 h at 37 °C prior to the
experiments. For each experiment, these cells were incubated
with four diﬀerent S-ION concentrations (10, 50, 100 and
200 µg ml−1) at 37 °C for 3 or 24 h, in incomplete or complete
cell culture medium.
The treatment doses and exposure times were selected from
the previous results of cell viability assays, as producing a
maximum decrease in viability of 30%.25 Incomplete or com-
plete cell culture media were used as negative controls in all
experiments. The following chemicals were used as positive con-
trols: Campt (10 μM) for apoptosis; Triton X-100 (1%) for mem-
brane integrity; MMC (1.5 µM) for the cell cycle and MN test;
and BLM (1 µg ml−1) for the comet assay and γH2AX analysis.
Cellular uptake
The potential of the S-ION to be taken up by the cells was
evaluated by means of flow cytometry using a FACSCalibur
flow cytometer (Becton Dickinson). After the treatments, the
analysis was carried out on the basis of size and complexity of
the cells by measuring the forward scatter (FSC) and the side
scatter (SSC), according to the protocol described.27
Cell cycle analysis
The cell distribution along the diﬀerent phases of the cell
cycle was examined in cells treated with S-ION or the controls
Paper Toxicology Research
236 | Toxicol. Res., 2016, 5, 235–247 This journal is © The Royal Society of Chemistry 2016
Pu
bl
ish
ed
 o
n 
23
 O
ct
ob
er
 2
01
5.
 D
ow
nl
oa
de
d 
on
 8
/7
/2
01
8 
5:
04
:2
2 
PM
. 
View Article Online
by measuring the relative cellular DNA content with a flow
cytometry technique (FACSCalibur flow cytometer, Becton
Dickinson), following the previously published protocol.28 An
estimated DNA content of approximately 104 events was
measured from the PI signal. Cell cycle histograms were ana-
lysed by Cell Quest Pro software (Becton Dickinson). Results
are reported as the average percentage of cells in each phase of
the cell cycle (G0/G1, S and G2/M). Complementarily, the subG1
region of the cell cycle distribution was also evaluated, indica-
tive of the late stages of apoptosis.29
Apoptosis and necrosis detection
A commercially available kit (BD Pharmingen™ Annexin-V
FITC apoptosis kit) was used to quantify the various modes of
cell death that may be potentially induced by S-ION treatment,
following the manufacturer’s recommendations. Approxi-
mately 104 events were acquired with a FASCalibur flow cyto-
meter (Becton Dickinson). Data from Annexin V-Fluorescein
isothiocyanate (FITC) and PI were analysed using Cell Quest
Pro software (Becton Dickinson). Early apoptosis and late
apoptosis/necrosis were expressed as the percentages of
Annexin V+/PI− and Annexin V+/PI+ cells, respectively.
Membrane integrity
A commercial kit (Roche Diagnostics) was used to measure the
lactate dehydrogenase (LDH) activity in cell culture media,
according to the manufacturer’s instructions. After exposure,
half the amount of the cell culture medium was collected for
LDH measurement. Absorption was measured at 490 nm with
a reference wavelength of 655 nm using a Cambrex
ELx808 microplate reader (Biotek, KC4). Triton X-100 (1%) was
taken as positive control and set as 100% cytotoxicity. LDH
release was calculated as follows:
LDH ð%Þ ¼ ½Asample  ½Amedium½Apositive control  ½Amedium
 100
where [A]sample, [A]medium and [A]positive control denote the absor-
bance of the sample, the corresponding medium negative
control and Triton X-100 positive control, respectively.
γH2AX assay
At the end of the exposure period, the level of phosphorylation
of H2AX histone at the serine 139 residue (γH2AX) was evalu-
ated using an anti-human γH2AX-Alexa Fluor 488-conjugated
antibody (Becton Dickinson), following previously published
protocols,30,31 with some modifications.32 A minimum of 104
events were acquired with a flow cytometer (FACSCalibur,
Becton Dickinson) to obtain data from Alexa Fluor 488 and PI
fluorescence intensities. Data were analysed using Cell Quest
Pro software (Becton Dickinson). Results are reported in each
case as the percentage of events positive for both dyes, Alexa
Fluor 488 and PI.
Micronuclei evaluation
After treatments with S-ION and controls, the cells were cul-
tured for an additional period of 24 h in fresh complete
medium. Next, a suspension of nuclei and MN was prepared
according to a previously reported procedure.33 The final sus-
pension was analysed with a FACSCalibur flow cytometer
(Becton Dickinson) as previously described.34
Comet assay
To evaluate DNA damage induction the alkaline comet assay
was performed after treating the cells with S-ION or the con-
trols, following the previously published protocol35 with minor
modifications.36 Comet IV Software (Perceptive Instruments)
was used for image capture and analysis. In all cases 100 cells
were scored (50 from each replicate slide), and the percentage
of DNA in the comet tail (tDNA%) was used as the DNA
damage parameter. Nevertheless, in order to be sure that the
nanoparticles tested do not interfere with the comet assay pro-
tocol, a modified version of the comet assay was performed
initially following the previously described protocol.37 Briefly,
untreated cells were centrifuged at 200g for 5 min at 4 °C. After
removing the supernatant, 40 μl S-ION were added directly to
the cells just before mixing them with 40 μl of 2% low-melting-
point (LMP) agarose, so that the final concentration of S-ION
was 200 μg ml−1, the highest dose to be tested for genotoxicity.
Then the alkaline comet assay was carried out following the
general protocol described above.
DNA repair competence assay
The experimental design previously described was followed
to evaluate the eﬀects of S-ION on DNA damage repair.38 It
consisted of three consecutive phases: (i) in phase A (pre-treat-
ment) cells were incubated for 3 or 24 h in the presence or
absence of S-ION (50 µg ml−1) at 37 °C; (ii) in phase B (DNA
damage induction) cells were challenged with H2O2 (100 µM)
for 5 min at 37 °C in the presence or absence of S-ION (50 µg
ml−1); and (iii) in phase C (repair) cells were washed in fresh
medium to remove treatment, and incubated with or without
S-ION (50 µg ml−1) for 30 min at 37 °C to allow DNA repair.
The alkaline comet assay was then performed after phase B
(data labelled as “before repair”) and phase C (data labelled as
“after repair”) as described previously.
Additionally, the cells were treated with S-ION (50 µg ml−1)
for 30 min and the comet assay was performed immediately
after. This was done to test whether 30 min incubation with
S-ION (as occurs in phase C) might induce significant damage
to DNA.
Statistical analysis
Statistical analyses were performed using SPSS for Windows
statistical package (version 20.0). A minimum of three inde-
pendent experiments were performed for each experimental
condition tested, and each condition was always run in dupli-
cate and under blind conditions. Experimental data were
expressed as mean ± standard error. Diﬀerences between the
groups were tested by using the Kruskal–Wallis test and
Mann–Whitney U-test. The associations between the two vari-
ables were analysed by Spearman’s correlation. A P-value of
less than 0.05 was considered significant.
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Results
The S-ION used in this study were previously characterized
regarding their physical–chemical features.25 In brief, trans-
mission electron microscopy measurements showed that they
are spherical particles with a mean diameter of 20.2 nm, and
the dynamic light scattering results revealed that they aggre-
gate to a low extent in both types of culture media (141.6 ±
1.4 nm in incomplete medium and 111.1 ± 1.1 nm in complete
medium). They have a negative zeta potential in water
(−31.8 mV) which decreases in cell culture media (−21.7 and
−10.3 mV in serum-free and complete media, respectively).
The release of iron ions from the S-ION was studied in
incomplete and complete cell culture media, and also in ALF
with respect to the influence of pH on nanoparticle degra-
dation. It was found to be very low in incomplete medium and
ALF solution when tested three times (3, 6 and 24 h) (Fig. 1).
Nevertheless, important concentrations of dissolved iron were
observed when S-ION were suspended in complete media, gen-
erally increasing with exposure time and nanoparticle dose.
Results obtained by testing the ability of S-ION to enter the
human neuroblastoma cells are shown in Fig. 2. The nano-
particles were eﬀectively internalized by the cells under all con-
ditions tested in a dose-dependent manner (incomplete
Fig. 1 Analysis of iron ions released from S-ION in (A) incomplete cell culture medium, (B) complete cell culture medium, and (C) artiﬁcial lysosomal
ﬂuid. Bars represent the mean standard error.
Fig. 2 (A) Neuronal cell uptake of S-ION prepared in incomplete and complete medium. Bars represent the mean standard error. **P < 0.01, signiﬁ-
cant diﬀerence with regard to the corresponding negative control. (B) Flow cytometry plot of control cells (left), and cells treated with 200 µg ml−1
S-ION for 3 h in incomplete medium (right). R2: Region of cells containing nanoparticles.
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medium: r = 0.824, P < 0.01 for 3 h treatment and r = 0.877, P <
0.01 for 24 h treatment; complete medium: r = 0.737, P < 0.01
for 3 h treatment and r = 0.692, P < 0.01 for 24 h treatment).
However, uptake was slightly higher in serum-free medium
than in complete medium, and for the highest dose tested it
was more prominent at 3 h than at 24 h treatment.
Fig. 3 shows the cell distribution during the various phases
of the cell cycle after exposing the neuronal cells to S-ION. The
3 h treatments, regardless of the medium employed, did not
modify the cell cycle, and significant alterations at 24 h treat-
ments were only observed for the 200 µg ml−1 concentration
(decrease in the G2/M phase and notable although not signifi-
cant increase in the S phase for treatment in incomplete
medium, and increase in the S phase for treatment in com-
plete medium). Besides, the subG1 region of the cell cycle dis-
tribution was also evaluated, since DNA fragmentation,
indicative of the late stages of apoptosis, results in the appear-
ance of PI-stained events containing subG1 levels;
29 results are
shown in Fig. 4. No significant increase in the subG1 fraction
was observed except for the cells exposed in serum-free
medium to the highest S-ION dose for 24 h.
To further investigate whether treatments with S-ION were
able to induce cell death by apoptosis or necrosis, a double
stain with Annexin V and PI was carried out. Results obtained
from the analyses showed that S-ION did not induce early
apoptosis (events positive for Annexin V but negative for PI) at
any concentration after 3 h of exposure regardless of the
medium used (Fig. 5). After 24 h of treatment significant
increases in the apoptosis rate could only be observed for the
highest doses assayed (200 µg ml−1 in incomplete medium
Fig. 3 Analysis of SHSY5Y cell cycle after 3 and 24 h of treatment with S-ION prepared in incomplete and complete medium. Bars represent the
mean standard error. PC: Positive control (MMC 1.5 µM). **P < 0.01, signiﬁcant diﬀerence with regard to the corresponding negative control.
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and 100 and 200 µg ml−1 in complete medium). No significant
induction of necrosis/late apoptosis (events positive for both
Annexin V and PI) was obtained under any experimental con-
ditions tested.
The potential alterations in the neuronal cell membrane
integrity caused by S-ION exposure were assessed by measur-
ing LDH activity in extracellular medium, since LDH is
released when the cell membrane is damaged. Results
obtained in this test are shown in Fig. 6. No significant altera-
tion in the percentage of LDH activity was observed at any
medium, concentration or treatment time tested.
The genotoxic potential of the S-ION was examined using
diﬀerent approaches. As a rapid screening method for geno-
toxicity, we first analysed H2AX phosphorylation, an early
Fig. 4 Apoptosis (% of cells in the subG1 region of cell cycle distribution) in neuronal cells treated with S-ION prepared in incomplete and complete
medium. Bars represent the mean standard error. PC: Positive control (MMC 1.5 µM). *P < 0.05, signiﬁcant diﬀerence with regard to the corres-
ponding negative control.
Fig. 5 Apoptosis and necrosis cell rates (%) after exposure of neuronal cells to S-ION for 3 and 24 h prepared in incomplete and complete medium.
Bars represent the mean standard error. PC: Positive control (Campt 10 μM). *P < 0.05, **P < 0.01, signiﬁcant diﬀerence with regard to the corres-
ponding negative control.
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cellular response to the induction of DNA double-strand
breaks (DSB). As can be clearly seen in Fig. 7, S-ION did not
induce γH2AX at either of the conditions analysed.
Next, we applied a relatively less specific approach, the MN
test scored by flow cytometry, in order to quantify chromoso-
mal alterations. The results of MN evaluation showed that no
significant changes were produced in the MN ratio after treat-
ment of the neuronal cells with the S-ION (Fig. 8).
The comet assay (single cell gel electrophoresis) was used
for measuring primary DNA damage in SHSY5Y cells caused
by exposure to S-ION. Due to the distinct physicochemical
characteristics of nanomaterials, several possible interferences
may occur with the comet assay methodology.39 Thus, a com-
prehensive test for detecting these interferences was carried
out before starting DNA damage evaluation, following Magdo-
lenova et al.37 As can be observed from Fig. 9, addition of
Fig. 6 Results of membrane integrity assessment (LDH assay) in SHSY5Y cells exposed to S-ION in incomplete and complete medium. Bars rep-
resent the mean standard error. PC: Positive control (Triton X-100 1%). **P < 0.01, signiﬁcant diﬀerence with regard to the corresponding negative
control.
Fig. 7 Phosphorylation of H2AX histone after treatment of neuronal cells with S-ION prepared in incomplete and complete medium. Bars represent
the mean standard error. PC: Positive control (BLM 1 µg ml−1). **P < 0.01, signiﬁcant diﬀerence with regard to the corresponding negative control.
Fig. 8 MN induction in neuronal cells after treatment with S-ION prepared in incomplete and complete medium. Bars represent the mean standard
error. PC: Positive control (MMC 1.5 µM). *P < 0.05, signiﬁcant diﬀerence with regard to the corresponding negative control.
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S-ION to the cells just before the lysis step was found not to
interfere with the subsequent steps of the experimental proto-
col, since no diﬀerences were found between the DNA damage
measured in the absence and in the presence of the nano-
particles. When the comet assay was applied to neuronal cells
treated with S-ION in serum-free medium, no significant
alteration in %tDNA was detected (Fig. 10). Nevertheless, dose-
dependent induction of DNA damage was observed in com-
plete medium (r = 0.948, P < 0.05 for 3 h treatment, and r =
0.842, P < 0.05 for 24 h treatment).
Results obtained in the DNA repair competence assay are
shown in Fig. 11. When cells were challenged with H2O2 and
no exposure to S-ION was carried out, there was a significant
decrease in the level of DNA damage after the 30 min repair
period in both media tested. When incubation with S-ION
was carried out before damage induction by H2O2 (phase A,
either 3 or 24 h), no repair was observed in serum-free
medium but %tDNA was significantly reduced in complete
medium, more pronounced in incubation for 24 h than for
3 h. Similar results were obtained when S-ION were applied
only during the 30 min repair period (phase C), although
treatment of cells for 30 min with only S-ION increased sig-
nificantly the DNA damage over the control level in both cell
culture media. However, the opposite occurred for experi-
ments where treatment with H2O2 and S-ION were performed
simultaneously (phase B), i.e., significant repair was
observed in incomplete medium and no repair in complete
medium.
Fig. 9 Results of interference testing between S-ION (200 µg ml−1) and
comet assay methodology in incomplete and complete medium. Bars
represent the mean standard error.
Fig. 10 DNA damage induction in neuronal cells after treatment with S-ION prepared in incomplete and complete medium. Bars represent the
mean standard error. PC: Positive control (BLM 1 µg ml−1). *P < 0.05, **P < 0.01, signiﬁcant diﬀerence with regard to the corresponding negative
control.
Fig. 11 Eﬀects of S-ION on repair of H2O2-induced DNA damage in neuronal cells. Incubation with S-ION was carried out either before H2O2 treat-
ment (phase A), simultaneously (phase B), or during the repair period (phase C). Bars represent the mean standard error. *P < 0.05, **P < 0.01,
signiﬁcant diﬀerence with regard to the same treatment before repair; #P < 0.05, signiﬁcant diﬀerence with regard to the control.
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Discussion
Magnetic nanoparticles are one of the first nanomaterials to
be approved for clinical use.40 Besides, because of their ability
to overcome the restraints of the blood–brain barrier,41 they
have been used as carriers for the transport of drugs, siRNA,
or DNA into the brain. To date, little is known on the eﬀects of
ION on the human nervous system. Few studies have been
published regarding the in vitro neurotoxicity of ION on
human neural cell lines, and results obtained are not
consistent.42–44
Due to its chemical stability, coating with silica can trans-
form ION by increasing their biocompatibility and oﬀering the
capacity to functionalize their surface without aﬀecting their
magnetic properties.45–47 Moreover, silica-coating helps to
convert hydrophobic nanoparticles into hydrophilic water-
soluble particles.48 Nevertheless, despite the numerous advan-
tages and potential applications in neuromedicine, the poss-
ible neurotoxicity of S-ION has not been completely discarded
yet.
There is a consensus that in vitro methods can provide
useful information concerning basic biological processes
underlying neurotoxicity, and specific information about the
mechanisms of action of neurotoxicants.49 Therefore human
SHSY5Y neuroblastoma cells were chosen as an appropriate
cell model widely used for studying neurotoxicity, since they
maintain many biochemical and functional properties of
neurons.50 The toxicity of S-ION on SHSY5Y cells was evaluated
using a range of concentrations (10–200 µg ml−1) and two
treatment times (3 and 24 h). As physicochemical properties of
nanomaterials may be quite diﬀerent depending on how they
are suspended, we also considered the possible diﬀerences in
toxicity of S-ION when they were prepared under biologically
relevant conditions (absence or presence of FBS).
Analysis of iron ion release from the S-ION suspensions
showed a diﬀerent behaviour of the nanoparticles depending
on the media composition. Low concentrations of iron were
detected in incomplete medium and ALF solution, whereas
the release of ions was notable in the presence of serum (com-
plete medium), in general increasing with time and S-ION con-
centration. Release of iron ions from ION was previously
described in a number of studies.51 However this release can
vary depending on the suspension conditions (e.g. pH) and the
nanoparticle surface coating.52 Results obtained here suggest
that degradation of the studied S-ION is not pH-dependent as
observed for other S-ION.52 Furthermore this degradation is
also not dependent on the particle size, since similar hydro-
dynamic diameters obtained in diﬀerent media showed very
diﬀerent dissolution rates.
The chemical synthesis, as well as the presence of a
coating, which surrounds and isolates the magnetic material
from the environment, and its physicochemical properties,
may influence the degradation rate of the particles and so the
release of iron ions.53,54 This would explain the diﬀerences
found in our study, since ION suspended in complete medium
may externally interact with serum proteins, thus favouring the
silica coating degradation and causing a higher iron release
from the nanoparticle core. In fact, proteins may increase the
dissolution rates of iron oxides through both aqueous com-
plexation and ligand-enhanced dissolution.55
The evaluation of cellular uptake of nanoparticles by flow
cytometry using the side scatter parameter (indicative of cell
granularity/complexity) is suitable for initial screening of
nanotoxicity.56 Experimental data confirmed that the S-ION
were eﬀectively taken up by neuroblastoma cells, and the
uptake was higher when exposure was performed in the
absence of serum. These findings agree with previous studies
in other cell types showing that S-ION are quickly internalized
by macrophages,57 and by A549 and HeLa cells.52 Diﬀerences
in nanoparticle uptake were previously reported by Krais et al.,
who studied the role of serum proteins on ION uptake, and
observed that the presence of a protein ‘corona’ may indeed
influence the cellular uptake of folic acid-functionalized
ION.58 Agreeing with our results, Salvati et al. speculated that
excessive binding of serum proteins may prevent selective,
ligand-mediated uptake of nanoparticles.59 Besides, our
in vitro studies revealed a remarkable lower degree of internaliz-
ation for the highest S-ION concentration at 24 h when com-
pared to the one obtained at 3 h. This is likely due to the
progressive nanoparticle agglomeration at this high concen-
tration, which causes a more noticeable interference with the
uptake process at the longest exposure period.
Cell cycle machinery corresponds to a series of events
which lead the cell to its division and duplication.60 Results
obtained from the analysis of the cell cycle showed that
exposure for 3 h to S-ION did not alter it at any concentration,
which agrees with previous findings from some other studies
using bare or diﬀerently coated ION.61 However, significant
mitotic arrest (increase in the rate of cells in the S phase and/
or decrease in the rate of cells in the G2/M phase) was observed
for 24 h treatments in both culture media at the highest dose
tested. Similar alterations in the cell cycle were observed by
Namvar et al. after exposing Jurkat cells to bare magnetite
nanoparticles prepared by green biosynthesis (using a brown
seaweed), but the dose used was much lower (6.4 µg ml−1,
corresponding to the inhibitory concentration 50 [IC50], calcu-
lated by the MTT assay).62 In the previous cell viability assays
with our S-ION,25 viabilities obtained for treatments up to 200
µg ml−1 were always higher than or equal to 70% as calculated
by MTT, neutral red uptake and alamar blue assays; therefore
cytotoxicity of the current nanoparticles, at least to SHSY5Y
cells, was much lower than cytotoxicity of the ION used by
Namvar et al. in Jurkat cells. These observations agree with the
general assumption that ION coated with silica are indeed less
toxic that bare ION. Besides, in a very recently published study,
Couto et al. were unable to find any alteration in the cell cycle
when testing polyacrylic acid (PAA)-coated and non-coated ION
on human T lymphocytes (48 h treatments).63
In order to evaluate apoptosis, which is critical in many
physiological and pathological processes, we used two alterna-
tive strategies: analysis of the subG1 region of the cell cycle dis-
tribution, indicative of DNA fragmentation at the late stages of
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apoptosis, and Annexin V/PI staining for sensitive detection of
early stage apoptosis. Results obtained with the two strategies
were quite similar. The only significant increase in apoptosis
rate observed was for the highest S-ION concentration after
24 h treatments in both media tested. The exception was the
subG1 region in complete medium, which did not show any
significant alteration. This diﬀerence may be explained on the
basis of the methodological diﬀerences between the two tech-
niques used. Annexin V/PI staining and measurement are
carried out just after the treatments, and reflect early stage
apoptosis, meanwhile subG1 region analysis is performed after
an additional 24 h incubation period following the treatments,
and is indicative of late stage apoptosis. Hence, probably the
cells undergoing early apoptosis detected by Annexin V/PI
staining have already been mostly removed when the subG1
region was analysed. Similar apoptosis results were reported
by Jeng and Swanson, who found that ION only induce apopto-
sis in mouse Neuro-2A neuroblastoma cells after exposure to
concentrations higher than 100 µg ml−1.64 Contrarily, Namvar
et al. described time-dependent (from 12 to 48 h) increases in
the apoptosis rates in Jurkat cells treated with bare magnetite
nanoparticles (6.4 µg ml−1), evaluated by the two same meth-
odologies used in the current work.62 Likewise, significant
apoptosis induction (evaluated by means of mitochondrial
membrane potential, JC-1 assay) in cervical and lung cells
exposed to 2.5 nM S-ION (magnetite) for 48 h was reported.52
This concentration is equivalent to approximately 30 µg ml−1
of our S-ION, dose which produced negative results under all
conditions tested in this study.
Cell death by necrosis (and/or late apoptosis) was also
determined by Annexin V/PI staining, and no alterations in
this rate were found in SHSY5Y cells exposed to S-ION in any
of the conditions assayed. Namvar et al. obtained contrary
results again: time-dependent increase in the necrosis/late
apoptosis rate in Jurkat cells treated with ION but, as men-
tioned above, toxicity of these nanoparticles (in terms of cell
viability decrease) was much higher.62
Possible eﬀects of S-ION exposure on cell membrane integ-
rity of neurons were evaluated by the LDH leakage assay. Nega-
tive results were obtained for all experimental conditions
evaluated, which is essentially in agreement with most results
obtained for cell cycle and apoptosis or necrosis induction,
and also with previous results from the same nanoparticles,
doses and cell line using MTT and alamar blue viability
assays.25 Nevertheless, positive LDH leakage results were
obtained by Malvindi et al. after treatment of A549 and HeLa
cells for 48 and 96 h with 2.5 nM S-ION (as already mentioned,
equivalent to 30 µg ml−1 of the current S-ION), according to
their apoptosis assessment results and confirming the lower
cytotoxicity of our silica-coated nanoparticles.52
Taking all cytotoxicity results together, S-ION tested showed
low cytotoxic potential; data from serum-free medium indicate
a slightly larger harmful potential [viability reduction,25 cell
cycle alterations and apoptosis induction (present study)],
agreeing with the faintly higher entrance of the nanoparticles
into the cells.
For testing the potential of S-ION to induce damage on the
genetic material, we used a battery of genotoxicity tests, i.e.,
the γH2AX assay, the MN test, and the comet assay. As a
response to the formation of DNA DSB, H2AX flanking the
DSB sites are rapidly phosphorylated at the serine 139 residue
to become γH2AX. Under normal conditions, γH2AX foci
appear within few minutes after the lesion, reach maximum
levels after about 30 min, and their half-life has been esti-
mated to be 2–7 h (reviewed in Valdiglesias et al.).65 Reliability
and specificity of the γH2AX assay as a biomarker of DNA
damage have already been proved.66,67 We used the γH2AX
assay evaluated by flow cytometry since it provides an auto-
mated, fast, practical, and reproducible high-throughput plat-
form that increases considerably the number of cells
evaluated, diminishing the variability and enhancing the stat-
istical power of the results.68 No significant increase in the
γH2AX levels was observed in SHSY5Y cells after exposure to
S-ION. No other study employing the γH2AX assay for testing
genotoxicity caused by any type of ION could be found in the
literature; however this cell line showed significant H2AX
phosphorylation activity when treated with ZnO nano-
particles69 but not when exposed to diﬀerent types of TiO2
nanoparticles.70
The purpose of the MN test is to identify chromosome aber-
rations, since MN may contain lagging chromosome fragments
or whole chromosomes; therefore it detects both clastogenic
and aneugenic events. After S-ION treatment no eﬀects were
observed in the neuronal cells in terms of MN formation. To
our knowledge no studies have been reported on MN induc-
tion by S-ION in any type of cells so far, but passiveness of
other types of ION on MN formation have been documented in
cells from a diﬀerent origin in in vitro71–73 and in vivo
studies.71,74,75
The comet assay is one of the most frequently used
methods for genotoxicity testing. Since it is simple, versatile,
and able to detect diﬀerent DNA lesions, it has been claimed
to be the most promising assay to measure potential geno-
toxicity of nanomaterials.76 Thus, we applied the alkaline
comet assay to examine primary DNA damage induced by
S-ION. But before that, we confirmed that these nanoparticles
do not interfere with the assay methodology, since inter-
ference of diﬀerent nanomaterials had been previously
reported.37,77,78 When treatments were carried out in serum-
free medium no significant induction of DNA damage was
observed. However, in complete medium S-ION induced dose-
and time-dependent increase in the comet parameter, in
agreement with the iron ion dissolution determination,
which showed significant amounts of ions released from the
nanoparticles in complete medium. Although the human
body contains relatively high concentrations of iron, the pres-
ence of this metal at concentrations higher than physiological
can lead to deleterious eﬀects. Iron ions are able to interact
with DNA in-between the bases, thereby unwinding the
double-helix79 and causing single strand breaks (SSB) and oxi-
dative base modification.80 This kind of damage, especially
SSB, is detected by the standard alkaline comet assay but is
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not related to phosphorylation of H2AX or MN production.
Therefore, this may help to explain the positive results
obtained in the comet assay and the negative ones from the
H2AX assay and the MN test. According to the current
results, the type of DNA damage induced by S-ION on neuro-
nal cells is likely not related to DSB but mostly to repairable
DNA lesions (alkali labile sites and SSB), indicating recent
damage.81 Similar increases in comet assay parameters
(tail length and tail DNA intensity) were reported by
Malvindi et al. in A549 and HeLa cells treated with S-ION,52
by Hong et al. in murine L-929 fibroblast cells exposed to
ION coated with (3-aminopropyl)trimethoxysilane (APTMS),
tetraethyl-orthosilicate (TEOS)–APTMS, or citrate,82 and by
Bhattacharya et al. in human lung IMR-90 fibroblasts and
bronchial epithelial BEAS-2B cells treated with bare hema-
tite.83 Moreover, no induction of chromosomal aberrations
(which require DSB production) was observed in human T
lymphocytes treated with PAA-coated and non-coated ION,63
which further supports our results.
Possible eﬀects of S-ION on DNA repair processes were
tested by the DNA repair competence assay using H2O2 as the
challenging agent. H2O2 causes damage to DNA by generating
hydroxyl-free radicals (OH•).84 These radicals attack DNA at the
sugar residue of the DNA backbone, leading to SSB.85
Rejoining of SSB induced by H2O2 is a simple cellular
process; thousands of breaks per cell can be repaired in a
matter of half an hour in typical cultured mammalian cells.81
In the current study, repair of approximately one-third of the
DNA damage observed after H2O2 treatment was obtained
during a 30 min period, both in incomplete and in complete
media. Incubation with the nanoparticles was carried out at
three diﬀerent stages of the assay: before inducing DNA
damage (pre-treatment or phase A, for 3 or 24 h), during DNA
damage induction (phase B), or during the repair period
(phase C). Results obtained were diﬀerent depending on the
presence of serum in the medium. In incomplete medium no
significant decrease in the DNA damage during the repair
phase was observed when S-ION incubation was carried out
before DNA damage induction, or during the repair phase.
Since incubation only with S-ION for 30 min caused a signifi-
cant increase in the comet parameter, maybe the negative
repair result obtained for phase C is related to DNA damage
induced directly by the S-ION instead of (or in addition) the
actual disturbance on the repair machinery. When treatment
with H2O2 and the nanoparticles was performed simul-
taneously the repair process occurred normally; a possible
explaining reason is the short time for this incubation (only
5 min), insuﬃcient to cause any alteration in the repair
systems.
The results observed in complete medium suggested scarce
eﬀects on DNA repair, since significant decreases in the DNA
damage were observed after the repair period under all con-
ditions tested, except for phase B. As indicated before, a
notable release of iron ions from the S-ION took place in com-
plete medium. The deleterious eﬀects of transition metal ions,
such as iron, to DNA are greatly enhanced by the presence of
oxygen and related species; thus, iron ions readily associate
with DNA and, in the presence of hydrogen peroxide, a high
ratio of DSB to SSB is generated.86 It is well known that the
repair of DSB can take hours.87 Therefore, the result obtained
for phase B in complete medium is probably more related to
the type of DNA damage induced (more DSB than SSB), for
which the 30 min repair period tested was not long enough,
than to alterations in the repair process. To the best of our
knowledge, this is the first study addressing the potential
eﬀects of ION on cellular repair systems. Therefore, further
investigations are required to go into detail about all these
findings.
Conclusion
Despite being eﬀectively internalized by the neuronal cells,
S-ION presented general low cytotoxicity; positive results were
only obtained in some assays at the highest concentrations
and/or the longest exposure time tested. Genotoxicity evalu-
ations in incomplete medium were negative for all conditions
assayed; in complete medium dose and time-dependent
increase in DNA damage, not related to the production of DSB
or chromosome loss (according to the results of the γH2AX
assay and the MN test), was obtained. Diﬀerences in the three
genotoxicity assays applied, regarding their sensitivity to detect
diﬀerent types of genetic damage, confirm the need for using
them in combination, since they complement one another.
The medium composition (presence or absence of serum)
influenced the behaviour of S-ION, although not to a great
extent. Uptake of the nanoparticles by the cells, cytotoxicity,
and eﬀects on DNA repair were more pronounced in the
absence of serum. On the contrary, iron ion release and
primary DNA damage were only observed in complete
medium. Formation of a protein corona in the presence of
serum has probably an important role in these diﬀerences.
Further studies are needed to determine the protein corona
formation and to elucidate the possible role of redox imbal-
ance in the generation of harmful eﬀects, particularly those
related to DNA damage.
Our study demonstrates how the preparation conditions,
beyond the intrinsic properties of the nanoparticles, may
determine the cytotoxic and genotoxic outcomes. Results
obtained in this work also highlight the importance of screen-
ing of possible interactions of nanoparticles with the living
systems, especially with the nervous system components, in
order to increase the knowledge on the eﬀects of nanoparticles
at diﬀerent levels to be able to guarantee manufacturers’ and
consumers’ safety.
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